Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hydroxysteroid dehydrogenase 4 pseudogene (ENSG00000253336) is a nonfunctional genomic sequence related to the family of 17beta-hydroxysteroid dehydrogenases. Unlike the functional enzyme genes in this family (such as HSD17B4, which is involved in steroid and fatty acid metabolism in peroxisomal beta-oxidation), this pseudogene does not encode an active protein. It is retained in the genome as a result of gene duplication or retrotransposition but has lost the ability to produce a functional enzyme. There is no evidence this pseudogene is expressed or involved in disease, drug response, or any biological process relevant to receptor, enzyme, transporter, or therapeutic target functions[1][2][5][4]. Key point: This entry refers to a pseudogene, not a protein-coding gene or functional molecular target. The related functional enzymes (such as HSD17B4) are important in human steroid metabolism and disease, but this pseudogene is not implicated in any recognized molecular pharmacology or biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxysteroid dehydrogenase 4 pseudogene.